Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Alamar Biosciences for the Transformative Bio-Hermes Studies
WASHINGTON, Jan. 09, 2026 (GLOBE NEWSWIRE) — The Global Alzheimer's Platform Foundation(R) (GAP) is pleased to welcome Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, to the Bio-Hermes studies. This collaboration will enhance the unique, observational platform studies that compare blood-based and digital biomarkers across a broad range of […]